دورية أكاديمية

Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management.

التفاصيل البيبلوغرافية
العنوان: Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management.
المؤلفون: Benitez Hidalgo, Olga, Martinez Garcia, M. Fernanda, Bescos Cabestre, Agustin, Juarez Gimenez, Juan Carlos, Gironella Mesa, Mercedes, Bosch Albareda, Francesc
المصدر: Clinical Case Reports; May2022, Vol. 10 Issue 5, p1-4, 4p
مصطلحات موضوعية: HEMOPHILIACS, NEUROSURGERY, SURGICAL complications, CHIMERIC proteins, HEMOPHILIA
مستخلص: Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who underwent neurosurgery. Hemophilia patients may need surgical interventions for complications either related or not to their coagulopathy. Real‐life experience is still limited using eftrenonacog alfa. This case demonstrates that it is an effective and safe treatment option. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Case Reports is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20500904
DOI:10.1002/ccr3.5848